• SPI Pharma Launches UltraBurst contractpharma
    July 13, 2021
    SPI Pharma has introduced UltraBurst, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristics—dissolution time. It is an innovative excipient platform for flash ODTs, enabling disintegration in under ten seconds.
PharmaSources Customer Service